Cardio-Oncology Prehabilitation Program to Improve Cardiac Reserve in High-Risk Patients Undergoing Hematopoietic Stem Cell Transplantation
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
To assess the feasibility and preliminary effectiveness of a Cardio-Oncology Prehabilitation program in patients at high-risk of developing Cardiovascular (CV) events in improving Cardiorespiratory fitness (CRF) and reducing acute CV complications in Hematopoietic stem cell transplant (HSCT) recipients.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Adult 18 years or older
• Referred for HSCT evaluation
• Presence of least one CV risk factor at enrollment (hypertension, hyperlipidemia, atrial fibrillation, obesity, heart failure, history of coronary artery disease, diabetes)
• Able to ambulate unassisted
• Ability to understand and the willingness to sign a written informed consent
• Ability to use Polar Flow heart rate application
Locations
United States
Michigan
University of Michigan Rogel Cancer Center
RECRUITING
Ann Arbor
Contact Information
Primary
Cancer AnswerLine
CancerAnswerLine@med.umich.edu
1-800-865-1125
Time Frame
Start Date: 2023-08-25
Estimated Completion Date: 2027-08
Participants
Target number of participants: 10
Treatments
Experimental: Cardio-oncology program
The cardio-oncology program consists of a multimodal approach, which includes individualized exercise prescription following a detailed CV assessment and medical management of CV risk factors occurring over 8 weeks.
Related Therapeutic Areas
Sponsors
Leads: University of Michigan Rogel Cancer Center
Collaborators: National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI)